ENTX Entera Bio Ltd.
Entera Bio Ltd. (ENTX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 9, 2026 , by Germano Geno J .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Germano Geno J | Director | Buy | 20,000 | $1.30 | $26.0K | 40,000 | |
| Ellis Sean | Director | Buy | 10,000 | $1.23 | $12.3K | 188,098 | |
| Rubin Steven D | Director | Buy | 5,000 | $1.49 | $7.5K | 15,000 | |
| Germano Geno J | Director | Buy | 20,000 | $1.49 | $29.8K | — | |
| Taitel Haya | Director | Buy | 7,500 | $1.48 | $11.1K | — | |
| Ellis Sean | Director | Buy | 18,000 | $1.24 | $22.3K | 178,098 | |
| Rubin Steven D | Director | Buy | 10,000 | $1.20 | $12.0K | 10,000 | |
| Toledano Miranda Jayne | Chief Executive Officer | Buy | 11,000 | $1.81 | $19.9K | 426,575 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.